Filter Results:
(1,488)
Show Results For
- All HBS Web
(1,488)
- People (1)
- News (333)
- Research (795)
- Multimedia (8)
- Faculty Publications (574)
Show Results For
- All HBS Web
(1,488)
- People (1)
- News (333)
- Research (795)
- Multimedia (8)
- Faculty Publications (574)
- December 2006 (Revised August 2008)
- Case
Pervasis Therapeutics, Inc.
By: Robert F. Higgins and Virginia Fuller
In May 2005, Steve Bollinger was about to become president and chief operating officer of Pervasis Therapeutics, a small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and... View Details
Keywords: Business Startups; Venture Capital; Financial Strategy; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Health Testing and Trials; Health Industry; Cambridge
Higgins, Robert F., and Virginia Fuller. "Pervasis Therapeutics, Inc." Harvard Business School Case 807-026, December 2006. (Revised August 2008.)
- August 2010 (Revised March 2012)
- Case
The UCLA Medical Center: Kidney Transplantation
By: Michael E. Porter, Jennifer F Baron, Jacob Mathew Chacko and Robin Jian Tang
In 2010, organ transplantation remained among the few sets of medical conditions in the U.S. for which bundled payments were a dominant reimbursement model, and for which patient health outcomes were universally measured and reported. In 1986, UCLA Medical Center was... View Details
Keywords: Insurance; Health Care and Treatment; Health Disorders; Measurement and Metrics; Outcome or Result; Competitive Strategy; Integration; Health Industry; California
Porter, Michael E., Jennifer F Baron, Jacob Mathew Chacko, and Robin Jian Tang. "The UCLA Medical Center: Kidney Transplantation." Harvard Business School Case 711-410, August 2010. (Revised March 2012.)
- 2023
- Working Paper
Healthcare Provider Bankruptcies
By: Samuel Antill, Jessica Bai, Ashvin Gandhi and Adrienne Sabety
Healthcare firms are increasingly filing for Chapter 11 bankruptcy. Using two strategies, we show causal evidence that bankruptcies harm patients through increased worker turnover. First, in an online experiment, experienced nurses assess hypothetical employers and... View Details
Keywords: Insolvency and Bankruptcy; Health Care and Treatment; Outcome or Result; Retention; Health Industry
Antill, Samuel, Jessica Bai, Ashvin Gandhi, and Adrienne Sabety. "Healthcare Provider Bankruptcies." Working Paper, November 2023.
- Web
Research Areas - Doctoral
analysis into practical solutions to real-world problems. 6. Finance researchers strive to understand how managers and firms make value-enhancing decisions; and how financial institutions, markets, and instruments contribute to this... View Details
- Web
Great American Business Leaders of the 20th Century - Leadership
Company, 1955–1966 Robert L. Johnson Black Entertainment Television, 1980–2001 Robert W. Johnson Johnson & Johnson Company, 1885–1910 Jesse H. Jones Reconstruction Finance Corporation, 1933–1939 Reginald H. Jones General Electric Company,... View Details
- January 2023
- Case
Thomas Buberl: Refounding AXA
By: Hubert Joly, Mihir Desai and Amram Migdal
In 2022, AXA and its CEO Thomas Buberl faced new types of challenges, including systemic risks such as climate change, geopolitical instability, public health crises, and social tensions caused by economic risks. AXA was one of the world’s largest insurers. Since... View Details
Keywords: Change; Change Management; Transformation; Transition; Trends; Environmental Management; Climate Change; Ethics; Values and Beliefs; Finance; Insurance; Management; Management Succession; Risk Management; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Planning; Strategic Planning; Risk and Uncertainty; Society; Human Needs; Social Issues; Strategy; Adaptation; Business Strategy; Corporate Strategy; Insurance Industry; Europe; France; Paris
Joly, Hubert, Mihir Desai, and Amram Migdal. "Thomas Buberl: Refounding AXA." Harvard Business School Case 523-059, January 2023.
- 30 Mar 2010
- First Look
First Look: March 30
outcomes salient (Burns & Corpus, 2004), the bias did not emerge when the presentation did not draw attention to recent outcomes. Fixing Health Care on the Front Lines Author:Richard M.J. Bohmer Publication:Harvard Business Review 88,... View Details
Keywords: Sean Silverthorne
- 02 Jan 2018
- First Look
First Look at New Research and Ideas, January 3, 2018
Sources of Inefficiency in Health Care By: Chandra, Amitabh, and Douglas O. Staiger Abstract—In medicine, the reasons for variation in treatment rates across hospitals serving similar patients are not well understood. Some interpret this... View Details
Keywords: Sean Silverthorne
- March 1993 (Revised June 1995)
- Case
Singapore TradeNet: The Tale Continues
By: Lynda M. Applegate, John L. King and Boon-Siong Neo
Continues the story of Singapore Network Services Pte. Ltd. (SNS), which was created to initiate and manage the creation of value-added networks for trade and other aspects of commerce in the island nation of Singapore. SNS built on its TradeNet experience to develop... View Details
Keywords: Internet and the Web; Information Infrastructure; Internet and the Web; Profit Sharing; Partners and Partnerships; Trade; Business and Government Relations; Web Services Industry; Singapore
Applegate, Lynda M., John L. King, and Boon-Siong Neo. "Singapore TradeNet: The Tale Continues." Harvard Business School Case 193-136, March 1993. (Revised June 1995.)
- Web
Class Profile - Doctoral
Pricing Corporate Governance Corporate Strategy Corporate Finance Diversity Emerging Markets Environment Ethics Experimental Economics Game Theory Health Care Incentives Innovation International Business... View Details
- Web
Accounting & Management - Faculty & Research
and Derek A. Haas Health care organizations have long tried to enlist physicians in their effort to control or reduce costs. One effective means for doing so is to create an incentive system that rewards physicians for their... View Details
- Web
Named Fellowship Funds - Alumni
health and medical research, youth services, and the arts. She served as national finance co-chair for Mitt Romney for President in 2008 and 2012, and as state finance chair... View Details
- February 1999
- Case
Lifeline Systems, Inc. (B)
By: H. Kent Bowen and Marilyn Matis
In 1997, Lifeline Systems continues to grow its service business to $32 million, 56% of the company's total revenues. More local hospital Lifeline programs turn over their monitoring service to Lifeline Central, expanding the company's subscriber base by 30%. The... View Details
Keywords: Health Care and Treatment; Information Technology; Expansion; Cost Management; Growth and Development Strategy; Partners and Partnerships; Change; Customer Relationship Management; Service Operations; Age; Investment; Health Industry; Health Industry; Cambridge; Boston
Bowen, H. Kent, and Marilyn Matis. "Lifeline Systems, Inc. (B)." Harvard Business School Case 699-038, February 1999.
- June 2009 (Revised June 2009)
- Case
VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture
This case describes the evolution of a liquid petroleum gas (LPG) distributor start-up, incubated by two not-for-profit NGOs to help improve the vaccine cold chain in Northern Mozambique. These NGOs must face the decision whether and how to sell their participation in... View Details
Keywords: Joint Ventures; Supply Chain; Health Care and Treatment; Investment; Non-Governmental Organizations; Energy Sources; Health Industry; Health Industry; Mozambique
Watson, Noel H., and Santiago Kraiselburd. "VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture." Harvard Business School Case 609-107, June 2009. (Revised June 2009.)
- Web
Podcast - Business & Environment
& Environment Initiative (LinkedIn) Guest: Bill Weir, Chief Climate Correspondent, CNN Drawdown Fund: Scaling the Impact of Climate Technology 14 AUG 2024 | Climate Rising Erik Snyder, Founder and CEO of Drawdown Fund discusses financing... View Details
- December 2004 (Revised March 2007)
- Case
Cutlass Capital, L.P.
By: Richard G. Hamermesh and Brian DeLacey
David Hetz and Jon Osgood are forming a new venture capital fund in 2001 to invest in health care start-ups. Describes their fundraising activities at a time when venture capital investing has reached an all-time high. Although their background skills and experiences... View Details
Keywords: Venture Capital; Negotiation Process; Entrepreneurship; Investment Funds; Health Care and Treatment; Business Startups; Health Industry; United States
Hamermesh, Richard G., and Brian DeLacey. "Cutlass Capital, L.P." Harvard Business School Case 805-075, December 2004. (Revised March 2007.)
- December 1999 (Revised August 2001)
- Case
Millennium Pharmaceuticals, Inc. (A)
By: Stefan H. Thomke and Ashok Nimgade
Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details
Keywords: Cost Management; Financing and Loans; Medical Specialties; Retention; Growth and Development Strategy; Time Management; Product Development; Problems and Challenges; Alliances; Technology; Biotechnology Industry; Pharmaceutical Industry; Cambridge
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (A)." Harvard Business School Case 600-038, December 1999. (Revised August 2001.)
- Program
Audit Committees in a New Era of Governance
method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis, and encourage you to apply as early as possible. Although most programs have... View Details
- December 2010
- Article
Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia
By: Nava Ashraf, James Berry and Jesse M. Shapiro
The controversy over how much to charge for health products in the developing world rests, in part, on whether higher prices can increase use, either by targeting distribution to high-use households (a screening effect), or by stimulating use psychologically through a... View Details
Ashraf, Nava, James Berry, and Jesse M. Shapiro. "Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia." American Economic Review 100, no. 5 (December 2010): 2383–2413. (Online Appendix.)
- June 2012
- Case
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
By: Arthur A. Daemmrich and Ian McKown Cornell
Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric... View Details
Keywords: Public-Private Partnerships; Business and Government Relations; Foreign Direct Investment; Health Care and Treatment; Globalized Firms and Management; Biotechnology Industry; Pharmaceutical Industry; Brazil
Daemmrich, Arthur A., and Ian McKown Cornell. "GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships." Harvard Business School Case 712-049, June 2012.